查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439276

神经诊断与监测设备 - 全球市场考量、竞争格局、市场预测 (2030)

Neurological Diagnostic and Monitoring Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球神经诊断和监测设备市场规模预计到2023年将达到118.1亿美元，到2030年将达到173.3亿美元，2024-2030年预测期间复合年增长率为6.66%。对神经诊断和监测设备的需求增加主要是由于神经系统疾病的盛行率不断上升、老年人口的不断增长、创伤性脑损伤的盛行率不断增加、产品组合的技术进步、神经系统疾病和适当的技术进步推动了这一趋势。政府加大努力，提高患者对早期诊断的认识，以便更好地进行管理。

神经诊断和监测设备的市场动态

由于全球癫痫、中风和帕金森氏症等神经系统疾病的盛行率不断上升，全球神经系统诊断和监测设备市场的成长正在迅速加速。根据世界卫生组织（2022）的数据，癫痫是一种慢性脑部疾病，影响全球约5,000万人，其中80%生活在低收入和中等收入国家，占全球疾病负担的很大一部分。据估计，透过正确的诊断和治疗，70%的癫痫患者将不再癫痫发作。

此外，世界各地脑肿瘤和癌症的发生率正在上升。例如，根据全球癌症观察站（2020）的统计，2020年全球新增脑肿瘤和中枢神经系统癌症病例308,102例。因此，患者数量的增加以及对这些疾病早期诊断的需求可能会增加对神经诊断和监测设备的需求，这有望进一步提振全球神经诊断和监测设备市场。

此外，利用先进技术的神经诊断设备的产品批准可能会快速成长全球神经诊断和监测设备市场。例如，最近在 2020 年 1 月，Compumedics Limited 的 Orion LifeSpanTM MEG 获得美国 FDA 批准，该产品配备了专利 DROS;SQUID 感测器系统。

然而，缺乏熟练的专业人员以及手术和脑监测设备的高昂成本等某些因素是限制全球神经诊断和监测设备需求的主要因素，特别是在报销政策较低的已开发国家。

神经诊断与监测设备市场细分分析

在神经诊断和监测设备产品领域，脑电图（EEG）在预测期内将占据很大的市场份额。这是因为独立和便携式 EEG 模型可提供各种通道，例如 8、21、25 和 32。此外，促进脑电图领域成长的其他因素包括製造商更加关注技术进步，例如减轻重量、便携性和同时收集原始数据。此外，临床实践和户外研究对便携式设备的需求不断增加预计将促进该领域的成长。

最近，2019 年，Nihon Kohden 推出了 VitalEEG(TM)，快速评估昏迷患者的大脑健康状况。该系统提供远端存取功能，允许临床医生从医院内的任何地方评估关键讯息，以及蓝牙通信，无需额外的电缆。

预计此类产品的推出也将在预测期内推动神经诊断和监测设备市场的细分市场成长。

北美预计将主导整个神经诊断和监测设备市场

预计在预测期内，北美将主导整个神经诊断和监测设备市场。这一优势是由于创伤性脑损伤 (TBI) 的盛行率不断上升、医疗成本不断上升以及该地区拥有发达且先进的医疗保健系统。此外，适当的报销政策也是一个驱动因素。

例如，根据 CDC 2022 年报告，2019 年美国约有 61,000 人因 TBI 相关死亡。研究也估计，美国约有 170 万人遭受创伤性脑损伤，其中 15 岁至 19 岁的青少年和 65 岁以上的成年人遭受创伤性脑损伤的风险最高。

本报告研究和分析了全球神经诊断和监测设备市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第1章 神经诊断及监护设备报告简介

第2章 神经诊断与监测设备摘要

  • 调查范围
  • 市场概况
  • 竞争评估

第3章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第4章 神经诊断与监护设备市场关键因素分析

  • 神经诊断和监测设备市场的驱动因素
    • 随着人口老化的加剧，神经系统疾病的盛行率不断增加
    • 创伤性脑损伤的盛行率增加
    • 我们产品组合的技术进步
    • 政府加强提高患者对神经系统疾病的认识以及早期诊断以进行适当的治疗
  • 神经诊断和监测设备市场的抑制因素和挑战
    • 设备和流程成本高
    • 熟练工人短缺
  • 神经诊断和监测设备市场的机会
    • 对非侵入式设备的需求不断增长
    • 发展中国家的市场成长机会

第5章 神经诊断监测设备的波特五力分析

第6章 神经诊断及监护设备市场布局

  • 按类型
    • 侵入性的
    • 非侵入性
  • 按产品类型
    • 脑磁图设备（MEG）
    • 脑电图设备（EEG）
    • 经颅多普勒超音波设备
    • 脑血氧仪
    • 颅内压监测仪
    • 其他
  • 按指示
    • 癫痫
    • 创伤性脑损伤
    • 中风
  • 按最终用户
    • 医院
    • 诊断中心/影像中心
  • 按地区
    • 北美神经诊断与监测设备市场规模
    • 欧洲神经诊断与监测设备市场规模（2021-2030）
    • 亚太地区神经诊断与监测设备市场规模（2021-2030）
    • 其他地区神经诊断及监护设备市场规模（2021-2030年）

第7章 神经诊断及监护设备公司及产品简介

  • Natus Medical, Inc
  • Nihon Kohden Corporation
  • Koninklijke Philips N.V.
  • Compumedics Limited
  • Croton Healthcare
  • Ricoh
  • Elekta AB
  • Integra LifeSciences
  • RAUMEDIC AG
  • Masimo
  • CadwellR Industries Inc.
  • Nonin
  • Neurosoft
  • Brain Scientific, Inc.
  • Recorders & Medicare Systems Pvt Ltd (RMS)
  • Rimed
  • Allengers
  • Medtronic
  • Edwards Lifesciences Corporation.
  • Ybrain, INC

第8章 KOL观点

第9章 专案方法

第10章 DelveInsight服务内容

第11章 关于 DelveInsight

第12章 免责声明与联络我们

Product Code: DIMDCL0066

Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive and Non-Invasive), Product Type (Magneto-Encephalography Devices (Meg), Electroencephalography Devices (Eeg), Transcranial Doppler Sonography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, and Others), Indication (Traumatic Brain Injuries, Epilepsy, Stroke, and Others), End-User (Hospitals, Diagnostic & Imaging Centers, and Others), and Geography is expected to grow at a static CAGR forecast till 2030 due to advances in product portfolio and burgeoning neurological disorder prevalence among the aging population.

The global neurological diagnostic and monitoring equipment market was valued at USD 11.81 billion in 2023, growing at a CAGR of 6.66% during the forecast period from 2024 to 2030, and will reach USD 17.33 billion by 2030. The rise in demand for neurological diagnostic and monitoring equipment is primarily motivated by the increasing prevalence of neurological disorders along with the rising aging population, growing incidence of traumatic brain injuries, technological advancement in the product portfolio, the rising government initiatives to raise awareness among patient regarding neurological disorders and their early diagnosis for proper management, among others.

Neurological Diagnostic and Monitoring Equipment Market Dynamics:

The global neurological diagnostic and monitoring equipment market growth is burgeoning due to the rising prevalence of neurological disorders such as epilepsy, stroke, and Parkinson's among others across the globe. According to WHO 2022, epilepsy is a chronic brain disorder that accounts for a significant proportion of the world's disease burden by affecting around 50 million people across the globe with 80% of the cases in low and middle-income nations. Also, the report mentions that an estimated 70% of people with epilepsy could be seizure-free if properly diagnosed and treated.

Moreover, the incidence of brain tumors and cancer among the world population is also on the rise. For instance, as per the Global Cancer Observatory 2020 statistics, globally there were 308,102 new cases of brain and central nervous system cancer new cases in 2020. Therefore, the rising patient population and the need for early diagnosis of these disorders could increase the demand for neurodiagnostic and monitoring devices which further is expected to boost the global neurological diagnostic and monitoring equipment market.

Further, product approval of technologically advanced neurodiagnostic devices is likely to upsurge the global neurological diagnostic and monitoring equipment market. For example, recently in January 2020, Compumedics Limited received US FDA approval for Orion LifeSpanTM MEG with a patented double relaxation oscillator superconducting quantum interference device (DROS; SQUID) sensor system.

However, certain factors such as the dearth of skilled professionals and the high cost of surgery and devices for brain monitoring are major factors limiting the global demand for neurological diagnostic and monitoring equipment, especially in developed countries with low reimbursement policies.

Neurological Diagnostic and Monitoring Equipment Market Segment Analysis:

Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive and Non-Invasive), Product Type (Magneto-Encephalography Devices (MEG), Electroencephalography Devices (EEG), Transcranial Doppler Sonography Devices, Cerebral Oximeters, Intracranial Pressure Monitors, and Others), Indication (Traumatic Brain Injuries, Epilepsy, Stroke, and Others), End-User (Hospitals, Diagnostic & Imaging Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the neurological diagnostic and monitoring equipment product segment, electroencephalography devices (EEG) hold a significant market during the forecasted period. This is owing to the availability of standalone as well as portable EEG models with different channels such as 8, 21, 25, and 32, among others. Moreover, other factors that contribute to the growth of the EEG segment are the growing focus of manufacturers towards technological advancements, such as lightweight, portability, and the acquisition of raw data simultaneously. Also, the increasing demand for portable devices for clinical practice and outdoor investigation is projected to augment the segment growth.

Furthermore, recently in 2019, Nihon Kohden launched VitalEEG(TM) to rapidly assess brain health in unconscious patients. The system provides both remote access functionality, so clinicians can assess critical information from anywhere in the hospital, and Bluetooth communication, eliminating the need for additional cables.

Thus such product launches are also expected to fuel the segmental growth of the neurological diagnostic and monitoring equipment market during the forecasted period.

North America is expected to dominate the overall Neurological Diagnostic and Monitoring Equipment Market:

North America is expected to dominate the overall neurological diagnostic and monitoring equipment market during the forecast period. This domination is due growing incidence of traumatic brain injuries (TBI), the increased healthcare expenditure along with the presence of well-developed and advanced healthcare systems in the region. Moreover, adequate reimbursement policies are the driving factors.

For instance, as per the CDC 2022 report, in 2019, there were nearly 61,000 TBI-related deaths in the US. Also, research studies have estimated that in the US, approximately 1.7 million people suffer a traumatic brain injury, with adolescents between ages 15 and 19 and adults aged 65 and older among the most likely to sustain a traumatic brain injury.

The presence of key market players such as Masimo Corporation, Compumedics Limited, and Natus Medical Incorporated, among others in the region is likely to boost the neurological diagnostic and monitoring equipment market.

Moreover, an increase in product approval in the region is also a driving factor for the Neurological Diagnostic and Monitoring Equipment in the region. For instance, in August 2020, Masimo announced that O3® Regional Oximetry has received FDA clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains.

Thus, the aforementioned factors are likely to upsurge the market for neurological diagnostic and monitoring equipment in the region.

Neurological Diagnostic and Monitoring Equipment Market Key Players:

Some of the key market players operating in the neurological diagnostic and monitoring equipment market include Natus Medical, Inc., Nihon Kohden Corporation, Koninklijke Philips N.V., Compumedics Limited, Croton Healthcare, Ricoh, Elekta AB, Integra LifeSciences, RAUMEDIC AG, Masimo, Cadwell® Industries Inc., Nonin, Neurosoft, Brain Scientific, Inc., Recorders & Medicare Systems Pvt Ltd (RMS), Rimed, Allengers, Medtronic, Edwards Lifesciences Corporation., Ybrain, INC, and others.

Recent Developmental Activities in the Neurological Diagnostic and Monitoring Equipment Market:

In March 2022, Brain Scientific received FDA Clearance for Next-Gen NeuroCap(TM) EEG Headset, an advanced Electroencephalogram (EEG) electrode array used to obtain rapid EEGs in routine clinical and research settings where the recording of STAT EEGs is desired.

In October 2020, MEGIN announced Japan Expansion by launching MEGIN KK in Tokyo.

In December 2019, Raumedic, a medical technology manufacturer, launched a new home-use device, named Raumed Home ICP, for intracranial pressure (ICP) monitoring. The product was developed for patients suffering from hydrocephalus.

Key Takeaways from the Neurological Diagnostic and Monitoring Equipment Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global neurological diagnostic and monitoring equipment market.

Various opportunities available for the other competitor in the neurological diagnostic and monitoring equipment market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for neurological diagnostic and monitoring equipment market growth in the coming future?

Target Audience who can be benefited from Neurological Diagnostic and Monitoring Equipment Market Report Study

Neurological Diagnostic and Monitoring Equipment providers

Research organizations and consulting companies

Neurological Diagnostic and Monitoring Equipment-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in neurological diagnostic and monitoring equipment

Various End-Users who want to know more about the neurological diagnostic and monitoring equipment market and the latest technological developments in the neurological diagnostic and monitoring equipment market.

Frequently Asked Questions for Neurological Diagnostic and Monitoring Equipment Market:

1. What is Neurological Diagnostic and Monitoring Equipment?

Neurological Diagnostic and Monitoring Equipment are the devices used for the diagnosis of neurological disorders such as stroke, migraine, epilepsy, Parkinson's disease, and ischemic stroke, among others. There are various equipment available in the market such as EEG, MEG, Cerebral Oximeters, among others.

2. What is the market for global neurological diagnostic and monitoring equipment?

The global Neurological Diagnostic and Monitoring Equipment Market was valued at USD 11.81 billion in 2023, growing at a CAGR of 6.66% during the forecast period from 2024 to 2030, and will reach USD 17.33 billion by 2030.

3. What are the drivers for global neurological diagnostic and monitoring equipment?

The major factors driving the demand for Neurological Diagnostic and Monitoring Equipment are the growing prevalence of neurological disorders coupled with the rising geriatric population, the increasing incidence of traumatic brain injuries, and the launch of technically advanced products in the market.

4. Who are the key players operating in global neurological diagnostic and monitoring equipment?

Some of the key market players operating in the neurological diagnostic and monitoring equipment market include natus medical, inc., Nihon Kohden Corporation, Koninklijke Philips N.V., Compumedics Limited, Croton Healthcare, Ricoh, Elekta AB, Integra LifeSciences, RAUMEDIC AG, Masimo, Cadwell® Industries Inc., Nonin, Neurosoft, Brain Scientific, Inc., Recorders & Medicare Systems Pvt Ltd (RMS), Rimed, Allengers, Medtronic, Edwards Lifesciences Corporation., Ybrain, INC, and others.

5. Which region has the highest share in the neurological diagnostic and monitoring equipment market?

North America is expected to dominate the overall neurological diagnostic and monitoring equipment market during the forecast period, 2024-2030. this domination is because of the increased healthcare expenditure along with the presence of well-developed and advanced healthcare systems in the region. Moreover, adequate reimbursement policies are the driving factors.

Table of Contents

1. Neurological Diagnostic and Monitoring Equipment Report Introduction

2. Neurological Diagnostic and Monitoring Equipment Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Neurological Diagnostic and Monitoring Equipment Market Key Factors Analysis

  • 4.1. Neurological Diagnostic and Monitoring Equipment Market Drivers
    • 4.1.1. Increasing prevalence of neurological disorders coupled with the rising aging population
    • 4.1.2. Growing Incidence of Traumatic Brain Injuries
    • 4.1.3. Technological advancement in the product portfolio
    • 4.1.4. Rising government initiative to raise awareness among patients regarding neurological disorders and their early diagnosis for proper management
  • 4.2. Neurological Diagnostic and Monitoring Equipment Market Restraints and Challenges
    • 4.2.1. High cost of the devices and procedure
    • 4.2.2. The dearth of skilled labors
  • 4.3. Neurological Diagnostic and Monitoring Equipment Market Opportunities
    • 4.3.1. Growing demand for non-invasive devices
    • 4.3.2. Market growth opportunities in developing nations

5. Neurological Diagnostic and Monitoring Equipment Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Neurological Diagnostic and Monitoring Equipment Market Layout

  • 6.1. By Type
    • 6.1.1. Invasive
    • 6.1.2. Non-invasive
  • 6.2. By Product Type
    • 6.2.1. Magnetoencephalography Devices (MEG)
    • 6.2.2. Electroencephalography Devices (EEG)
    • 6.2.3. Transcranial Doppler Sonography Devices
    • 6.2.4. Cerebral Oximeters
    • 6.2.5. Intracranial Pressure Monitors
    • 6.2.6. Others
  • 6.3. By Indication
    • 6.3.1. Epilepsy
    • 6.3.2. Traumatic Brain Injuries
    • 6.3.3. Stroke
    • 6.3.4. Others
  • 6.4. By End-User
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic & Imaging Centers
    • 6.4.3. Others
  • 6.5. By Geography
    • 6.5.1. North America Neurological Diagnostic and Monitoring Equipment Market Size in USD million 2021-2030)
      • 6.5.1.1. United States Neurological Diagnostic and Monitoring Equipment Market Size in USD million 2021-2030)
      • 6.5.1.2. Canada Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.1.3. Mexico Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
    • 6.5.2. Europe Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.1. France Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.2. Germany Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.3. United Kingdom Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.4. Italy Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.5. Spain Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.2.6. Rest of Europe Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
    • 6.5.3. Asia-Pacific Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.1. China Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.2. Japan Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.3. India Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.4. Australia Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.5. South Korea Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.3.6. Rest of Asia Pacific Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
    • 6.5.4. Rest of the World (RoW) Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.4.1. Middle East Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.4.2. Africa Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)
      • 6.5.4.3. South America Neurological Diagnostic and Monitoring Equipment Market Size in USD million (2021-2030)

7. Neurological Diagnostic and Monitoring Equipment Company and Product Profiles

  • 7.1. Natus Medical, Inc
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Nihon Kohden Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Koninklijke Philips N.V.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Compumedics Limited
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Croton Healthcare
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Ricoh
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Elekta AB
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Integra LifeSciences
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. RAUMEDIC AG
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Masimo
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Cadwell® Industries Inc.
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Nonin
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Neurosoft
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Brain Scientific, Inc.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Recorders & Medicare Systems Pvt Ltd (RMS)
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. Rimed
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Allengers
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. Medtronic
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. Edwards Lifesciences Corporation.
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Ybrain, INC
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Neurological Diagnostic and Monitoring Equipment Market in Global (2021-2030)
  • Table 3: Neurological Diagnostic and Monitoring Equipment Market in Global by Type (2021-2030)
  • Table 4: Neurological Diagnostic and Monitoring Equipment Market in Global by Product Type (2021-2030)
  • Table 5: Neurological Diagnostic and Monitoring Equipment Market in Global by Indication (2021-2030)
  • Table 6: Neurological Diagnostic and Monitoring Equipment Market in Global by End-User (2021-2030)
  • Table 7: Neurological Diagnostic and Monitoring Equipment Market in Global by Geography (2021-2030)
  • Table 8: Neurological Diagnostic and Monitoring Equipment Market in North America (2021-2030)
  • Table 9: Neurological Diagnostic and Monitoring Equipment Market in the US (2021-2030)
  • Table 10: Neurological Diagnostic and Monitoring Equipment Market in Canada (2021-2030)
  • Table 11: Neurological Diagnostic and Monitoring Equipment Market in Mexico (2021-2030)
  • Table 12: Neurological Diagnostic and Monitoring Equipment Market in Europe (2021-2030)
  • Table 13: Neurological Diagnostic and Monitoring Equipment Market in France (2021-2030)
  • Table 14: Neurological Diagnostic and Monitoring Equipment Market in Germany (2021-2030)
  • Table 15: Neurological Diagnostic and Monitoring Equipment Market in the United Kingdom (2021-2030)
  • Table 16: Neurological Diagnostic and Monitoring Equipment Market in Italy (2021-2030)
  • Table 17: Neurological Diagnostic and Monitoring Equipment Market in Spain (2021-2030)
  • Table 18: Neurological Diagnostic and Monitoring Equipment Market in Rest of Europe (2021-2030)
  • Table 19: Neurological Diagnostic and Monitoring Equipment Market in Asia-Pacific (2021-2030)
  • Table 20: Neurological Diagnostic and Monitoring Equipment Market in China (2021-2030)
  • Table 21: Neurological Diagnostic and Monitoring Equipment Market in Japan (2021-2030)
  • Table 22: Neurological Diagnostic and Monitoring Equipment Market in India (2021-2030)
  • Table 23: Neurological Diagnostic and Monitoring Equipment Market in Australia (2021-2030)
  • Table 24: Neurological Diagnostic and Monitoring Equipment Market in South Korea (2021-2030)
  • Table 25: Neurological Diagnostic and Monitoring Equipment Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Neurological Diagnostic and Monitoring Equipment Market in the Rest of the World (2021-2030)
  • Table 27: Neurological Diagnostic and Monitoring Equipment Market in the Middle East (2021-2030)
  • Table 28: Neurological Diagnostic and Monitoring Equipment Market in Africa (2021-2030)
  • Table 29: Neurological Diagnostic and Monitoring Equipment Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Neurological Diagnostic and Monitoring Equipment Market in Global (2021-2030)
  • Figure 3: Neurological Diagnostic and Monitoring Equipment Market in Global by Type (2021-2030)
  • Figure 4: Neurological Diagnostic and Monitoring Equipment Market in Global by Product Type (2021-2030)
  • Figure 5: Neurological Diagnostic and Monitoring Equipment Market in Global by Indication (2021-2030)
  • Figure 6: Neurological Diagnostic and Monitoring Equipment Market in Global by End-User (2021-2030)
  • Figure 7: Neurological Diagnostic and Monitoring Equipment Market in Global by Geography (2021-2030)
  • Figure 8: Neurological Diagnostic and Monitoring Equipment Market in North America (2021-2030)
  • Figure 9: Neurological Diagnostic and Monitoring Equipment Market in the US (2021-2030)
  • Figure 10: Neurological Diagnostic and Monitoring Equipment Market in Canada (2021-2030)
  • Figure 11: Neurological Diagnostic and Monitoring Equipment Market in Mexico (2021-2030)
  • Figure 12: Neurological Diagnostic and Monitoring Equipment Market in Europe (2021-2030)
  • Figure 13: Neurological Diagnostic and Monitoring Equipment Market in France (2021-2030)
  • Figure 14: Neurological Diagnostic and Monitoring Equipment Market in Germany (2021-2030)
  • Figure 15: Neurological Diagnostic and Monitoring Equipment Market in the United Kingdom (2021-2030)
  • Figure 16: Neurological Diagnostic and Monitoring Equipment Market in Italy (2021-2030)
  • Figure 17: Neurological Diagnostic and Monitoring Equipment Market in Spain (2021-2030)
  • Figure 18: Neurological Diagnostic and Monitoring Equipment Market in Rest of Europe (2021-2030)
  • Figure 19: Neurological Diagnostic and Monitoring Equipment Market in Asia-Pacific (2021-2030)
  • Figure 20: Neurological Diagnostic and Monitoring Equipment Market in China (2021-2030)
  • Figure 21: Neurological Diagnostic and Monitoring Equipment Market in Japan (2021-2030)
  • Figure 22: Neurological Diagnostic and Monitoring Equipment Market in India (2021-2030)
  • Figure 23: Neurological Diagnostic and Monitoring Equipment Market in Australia (2021-2030)
  • Figure 24: Neurological Diagnostic and Monitoring Equipment Market in South Korea (2021-2030)
  • Figure 25: Neurological Diagnostic and Monitoring Equipment Market in Rest of Asia-Pacific (2021-2030)
  • Figure 26: Neurological Diagnostic and Monitoring Equipment Market in the Rest of the World (2021-2030)
  • Figure 27: Neurological Diagnostic and Monitoring Equipment Market in the Middle East (2021-2030)
  • Figure 28: Neurological Diagnostic and Monitoring Equipment Market in Africa (2021-2030)
  • Figure 29: Neurological Diagnostic and Monitoring Equipment Market in South America (2021-2030)
  • Figure 30: Market Drivers
  • Figure 31: Market Barriers
  • Figure 32: Market Opportunities
  • Figure 33: PORTER's Five Force Analysis